Aguettant Nordic is founded in 2019, operates from its headquarter in Copenhagen, DK. The company operates in the Manufacturing, Pharmaceuticals sector.
Aguettant Nordic specializes in Development of injectable pharmaceutical specialties, Industrial production of sterile injectable medicines, Research in ready-to-administer products, and offers services including Essential sterile injectable medicines, Pre-Filled Syringes (PFS), and Ready-to-administer products.